Researcher comment: The KEYNOTE-604 trial | Charles Rudin

(5:2)

Researcher comment: The TheraP trial | Michael Hofman

(4:25)

Researcher comment: The KEYNOTE-355 trial | Javier Cortes

(5:37)

Researcher comment: The KEYNOTE-146/Study 111 trial | Chung-Han Lee

(4:58)

Researcher comment: Final analysis of KEYNOTE-189 | Delvys Rodriguez-Abreu

(4:52)

Researcher comment: The 2-year outcomes of the DiRECT trial | Roy Taylor

(6:45)

হাসিনার উস্কানি কাল হলো আওয়ামী লীগের জন্য; প্যালেস্টাইন নিয়ে চলছে ষড়যন্ত্র | Our Democracy| EP 1037

(44:29) 172

Jeremy Corbell: UFO Revolution || That UFO Podcast

(1:44:18)

Et si c'était nous les extraterrestres ? Les travaux fascinants de l'astrobiologiste Nathalie Cabrol

(56:25)

Un peu de science pour comprendre la crise sismique de janvier-février 2025 à Santorin

(55:12)

I tested DeepSeek vs. OpenAI-o1 for data science tasks: Here’s what I found.

(15:12)

Iranian Researchers Claim Black Biblical Israelites Were the Original Hebrews.

(28:58)

A Slightly Technical Breakdown of DeepSeek-R1

(11:38)

Google Gemini Deep Research + NotebookLM - Ultimate AI Combo

(13:27)

10 Incredible Use Cases: ChatGPT Operator Agent (Must See!)

(29:11)

Researcher comment: The SAVOIR trial | Toni Choueiri

(4:24)

Researcher comment: SELECT-PsA-2 | Philip Mease

(6:18)

3D Numerical Analysis of Vortex Tubes: Fluid Performance Unveiled! #sciencefather #researcher

(41)

Researcher comment: The PrE0505 study | Patrick Forde

(6:24)

Researcher comment: The CONTROL trial | Laura Coates

(4:36)

Researcher comment: CheckMate 817 trial of nivolumab–ipilimumab | Fabrice Barlesi

(3:32)

Researcher comment: Initial data from CCC19 | Jeremy Warner

(14:41)

Researcher comment: The BLASST-1 trial | Shilpa Gupta

(3:16)

Researcher comment: Updated KEYNOTE-426 data | Elizabeth Plimack

(1:46)

Researcher comment: 5-year KEYNOTE-001 results | Edward Garon

(4:13)

Researcher comment: SELECT-PsA-1 | Frank Behrens

(7:49)

Researcher comment: The SPIRIT-P3 study | Laura Coates

(4:2)

Researcher comment: The FINCH 1 trial

(7:20)

Researcher comment: Perioperative durvalumab for locally advanced RCC | Moshe Ornstein

(5:18)